Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2015 by PATH
Sponsor:
Collaborators:
Bill and Melinda Gates Foundation
Information provided by (Responsible Party):
PATH
ClinicalTrials.gov Identifier:
NCT02165202
First received: May 21, 2014
Last updated: February 24, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2017
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)